Inhibition of HIV-1 replication by combined expression of gag dominant negative mutant and a human ribonuclease in a tightly controlled HIV-1 inducible vector

被引:16
作者
Cara, A
Rybak, SM
Newton, DL
Crowley, R
Rottschafer, SE
Reitz, MS
Gusella, GL
机构
[1] NCI, Frederick Canc Res & Dev Ctr, Lab Biochem Physiol, Div Basic Sci, Frederick, MD 21702 USA
[2] NCI, Basic Res Lab, NIH, Bethesda, MD 20892 USA
[3] NCI, Frederick Canc Res & Dev Ctr, Intramural Res Program, SAIC Frederick, Frederick, MD 21701 USA
[4] Inst Human Virol, Baltimore, MD USA
关键词
gene therapy; HIV-1; ribonuclease; internal ribosome entry site; replication;
D O I
10.1038/sj.gt.3300545
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An HIV-1-based expression vector has been constructed that produces protective genes tightly regulated by HIV-1 Tat and Rev proteins. The vector contains either a single protective gene (HIV-1 gag dominant negative mutant (delta-gag)) or a combination of two different protective genes (delta-gag and eosinophil-derived neurotoxin (EDN), a human ribonuclease) which are expressed from a di-cistronic mRNA. After stable transfection of CEM T cells and following challenge with HIV-1, viral production was completely inhibited in cells transduced with the vector producing both delta-gag and EDN and delayed in cells producing delta-gag alone. In addition, cotransfection of HeLa-Tat cells with an infectious HIV-1 molecular clone and either protective vector demonstrated that the HIV-1 packaging signals present in the constructs were functional and allowed the efficient assembly of the protective RNAs into HIV-1 virions, thus potentially transmitting protection to the HIV-1 target cells.
引用
收藏
页码:65 / 75
页数:11
相关论文
共 34 条
  • [1] [Anonymous], 1989, SYNTHETIC OLIGONUCLE
  • [2] BENKO D M, 1990, New Biologist, V2, P1111
  • [3] Bohan Cindy A., 1992, Gene Expression, V2, P391
  • [4] ANALYSIS OF CD4 GENE-EXPRESSION IN HUMAN FETAL BRAIN AND NEUROBLASTS
    CARA, A
    PECORARA, M
    CORNAGLIAFERRARIS, P
    [J]. CELLULAR AND MOLECULAR NEUROBIOLOGY, 1992, 12 (02) : 131 - 142
  • [5] SELF-LIMITING, CELL TYPE-DEPENDENT REPLICATION OF AN INTEGRASE-DEFECTIVE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN HUMAN PRIMARY MACROPHAGES BUT NOT T-LYMPHOCYTES
    CARA, A
    GUARNACCIA, F
    REITZ, MS
    GALLO, RC
    LORI, F
    [J]. VIROLOGY, 1995, 208 (01) : 242 - 248
  • [6] HIV-1 protein expression from synthetic circles of DNA mimicking the extrachromosomal forms of viral DNA
    Cara, A
    Cereseto, A
    Lori, F
    Reitz, MS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (10) : 5393 - 5397
  • [7] A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-BASED RETROVIRAL VECTOR SYSTEM UTILIZING STABLE HIV-1 PACKAGING CELL-LINES
    CARROLL, R
    LIN, JT
    DACQUEL, EJ
    MOSCA, JD
    BURKE, DS
    STLOUIS, DC
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (09) : 6047 - 6051
  • [8] SELECTIVE KILLING OF CD4+ CELLS HARBORING A HUMAN IMMUNODEFICIENCY VIRUS-INDUCIBLE SUICIDE GENE PREVENTS VIRAL SPREAD IN AN INFECTED CELL-POPULATION
    CARUSO, M
    KLATZMANN, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (01) : 182 - 186
  • [9] RNA SECONDARY STRUCTURE AND BINDING-SITES FOR GAG GENE-PRODUCTS IN THE 5'-PACKAGING SIGNAL OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CLEVER, J
    SASSETTI, C
    PARSLOW, TG
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (04) : 2101 - 2109
  • [10] ESSEX M, 1995, LEUKEMIA S1, V9, P71